Pharmaceutical innovation succeeds every day, yet patient access too often does not.
Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.
In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.
Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.
For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches.
外文書商品之書封，為出版社提供之樣本。實際出貨商品，以出版社所提供之現有版本為主。部份書籍，因出版社供應狀況特殊，匯率將依實際狀況做調整。
無庫存之商品，在您完成訂單程序之後，將以空運的方式為你下單調貨。為了縮短等待的時間，建議您將外文書與其他商品分開下單，以獲得最快的取貨速度，平均調貨時間為1~2個月。
為了保護您的權益，「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨，請在商品鑑賞期內寄回，且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。
